Assessment of anti-sperm antibodies in couples after testicular sperm extraction

Ufuk Ozturk, Erkan Ozdemir, Onur Dede, Levent Sagnak, HN Goksel Goktug, Oguz A Gurbuz, Mustafa Mustafa, M Abdurrahim İmamoglu


Purpose: Testicular spermatozoa can be retrieved successfully by the testicular sperm extraction (TESE) procedure and used for intracytoplasmic sperm injection. Disruption in the blood-testis barrier can lead to the production of antisperm antibodies (ASA). The aim of this prospective study was to investigate the frequency of ASA formation in couples after TESE procedure.

Methods: Thirty-seven couples were included in the study at the Urology Clinic of the Dr. Zekai Tahir Burak Women’s Health Training and Research Hospital. History, physical examination, spermiogram, and endocrine profiles were obtained for all male patients. All the male patients in this study had been diagnosed with nonobstructive azoospermia (NOA) and underwent microdissection TESE. Secondary and tertiary cases were also included in the study. Serum samples were obtained from all 74 patients before TESE, and at three and 12 months after TESE. Serum ASA levels were determined. ANOVA was performed for statistical analysis for serum Follicle-Stimulating Hormone (FSH), testosterone and testicular volume. P < 0.05 was considered significant.

Results: There were no differences in the testicular volumes, serum FSH and testosterone levels before and after TESE. None of the patients or their partners developed significant levels of ASA as a result of the TESE procedure.

Conclusion: TESE procedure does not cause ASA production in either males or their female partners.

Full Text:




  • There are currently no refbacks.

© 2007-2017 Canadian Society for Clinical Investigation.
C.I.M. provides open access to all of its content 6 months after the date of publication